In 614 HBsAg-positive Yugoslavian patients, radioimmunoassay testing f
or anti-delta showed the presence of this antibody in serum in 11.2%.
Of the patients. 213 belonged to a risk group (i.v. drug users, hemoph
iliacs. hemodialysed patients and patients with posttransfusion hepati
tis): a significant number of these patients (63; 29.6%) were found to
have anti-delta. A second group was composed of 401 HBsAg-positive pa
tients from the general population (patients with acute hepatitis B. w
ith fulminant hepatitis B and patients with chronic HBV infection), de
lta infection was found only in six (1.5%). Immunohistochemical method
s failed to demonstrate the delta antigen in the livers of 73 patients
with chronic HBV infection. Testing the liver of 36 patients with ful
minant hepatitis B for delta antigen demonstrated this reactivity in o
nly one (2.8%) liver sample. Delta antigen was also found in the liver
of a female patient who underwent biopsy in 1972. The results of this
study suggest the:HDV is not endemic in Yugoslavia; however. it is fr
equently found in patients at risk of blood exposure. primarily i.v. d
rug users.